(Q35431110)

English

Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

zoledronic acid

1 reference

based on heuristic

inferred from title

Elizabeth Barrett-Connor

6

object named as

Elizabeth Barrett-Connor

0 references

object named as

Jane A Cauley

3

0 references

Kristine Ensrud

5

object named as

Kristine E Ensrud

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

7

object named as

Dennis M Black

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Steven R Cummings

2

object named as

Steven R Cummings

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Douglas C Bauer

4

object named as

Douglas C Bauer

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1

object named as

Trisha F Hue

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

JAMA Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

174

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1550-1557

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Exposure to oral bisphosphonates and risk of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Bisphosphonates and breast cancer incidence and recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Breast-cancer adjuvant therapy with zoledronic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Oral bisphosphonate use and breast cancer incidence in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Bisphosphonates induce breast cancer cell death in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Confounding and indication for treatment in evaluation of drug treatment for hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Decreased mortality in users of estrogen replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

27 July 2018

Use of bisphosphonates and risk of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Factors associated with 5-year risk of hip fracture in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Differential effects of bisphosphonates on breast cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Design of the Fracture Intervention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4398333

26 September 2018

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor characteristics and clinical outcome of elderly women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confounding by indication

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen replacement therapy after coronary angioplasty in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen replacement therapy and prognosis after first myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect on survival of estrogen replacement therapy after coronary artery bypass grafting

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of bisphosphonates and risk of postmenopausal breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25111880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMAINTERNMED.2014.3634

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35431110&oldid=1984450724"